Format

Send to

Choose Destination
Cell. 2014 Jan 30;156(3):603-616. doi: 10.1016/j.cell.2013.12.029.

Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules.

Author information

1
Department of Industrial and Systems Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
2
Brain Tumor Center, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
3
Departments of Neurosciences and Molecular Medicines, Cleveland, OH 44195, USA.
4
Center for Molecular Imaging and Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
5
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
6
Division of Human Biology, Alvord Brain Tumor Center, University of Washington, Seattle, WA 98109, USA.
7
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
8
Department of Biostatistics, Harvard School of Public Health, Boston, MA 02215, USA.
#
Contributed equally

Abstract

Glioblastomas (GBMs) are the most common and malignant primary brain tumors and are aggressively treated with surgery, chemotherapy, and radiotherapy. Despite this treatment, recurrence is inevitable and survival has improved minimally over the last 50 years. Recent studies have suggested that GBMs exhibit both heterogeneity and instability of differentiation states and varying sensitivities of these states to radiation. Here, we employed an iterative combined theoretical and experimental strategy that takes into account tumor cellular heterogeneity and dynamically acquired radioresistance to predict the effectiveness of different radiation schedules. Using this model, we identified two delivery schedules predicted to significantly improve efficacy by taking advantage of the dynamic instability of radioresistance. These schedules led to superior survival in mice. Our interdisciplinary approach may also be applicable to other human cancer types treated with radiotherapy and, hence, may lay the foundation for significantly increasing the effectiveness of a mainstay of oncologic therapy. PAPERCLIP.

Comment in

PMID:
24485463
PMCID:
PMC3923371
DOI:
10.1016/j.cell.2013.12.029
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center